Latest news
Loading news…
Optipharm
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cheongju, Ch'ungch'ong-bukto, South Korea Founded 2000 11-50 employees For Profit
Optipharm provides a biomedical solution that is involved in the development of cell therapy products using animal stem cells.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
22
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 13
- Patents granted
- 22
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
Company Info
- Founded
- 2000
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Cheongju, Ch'ungch'ong-bukto, South Korea
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- Low
- Growth score
- Medium
- Trend (7d)
- -0.1
- Trend (30d)
- -0.4
- Trend (90d)
- 0
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Optipharm
Loading news…
FAQs about Optipharm
People who checked this page also checked these
Browse the full Acquirezy directory.